McKhann G, Drachman D, Folstein M, et al.: Clinical diagnosis of Alzheimer 's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34: 939-944.
2.
Fox P: From senility to Alzheimer's disease: The rise of the Alzheimer 's disease movement. Milbank Q. 1989: 67(1): 58-102.
3.
Müller U, Wolf H, Kiefer M, et al.: Nationale und Internationale Demenz-Leitlinien im Vergleich. Fortschr Neurol Psychiatr. 2003; 71: 285-295.
4.
Josephs KA, Tsuboi Y, Cookson N, et al.: Apolipoprotein E-4 is a determinant for Alzheimer-type pathologic features in tauopathies, synucleinopathies, and frontotemporal degeneration. Arch Neurol. 2004; 61: 1579-1584.
5.
Neuropathology Group, Medical Research Council Cognitive Function and Aging Study: Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet. 2001; 357: 169-175.
6.
Mirra SS, Heyman A, McKeel D, et al.: The Consortium to Establish a Registry for Alzheimer's Disease [CERAD]. Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 1991; 41: 479-486.
7.
Xuereb JH, Brayne C, Dufouil C, et al.: Neuropathological findings in the very old. Results from the first 101 brains of a populationbased longitudinal study of dementing disorders. Ann N Y Acad Sci. 2000; 903: 490-496.
8.
Jellinger KA, Mitter-Ferstl E: The impact of cerebrovascular lesions in Alzheimer disease—A comparative autopsy study. J Neurol. 2003; 250: 1050-1055.
9.
Barker WW, Luis CA, Kashuba A, et al.: Relative frequencies of Alzheimer disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Dis Assoc Disord. 2002; 16: 203-212.
10.
Flier vd WM, Van Den Heuvel DM, Weverling-Rijnsburger AW, et al.: Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology. 2002; 59: 874-879.
11.
Flier vd WM, Middelkoop HA, Weverling-Rijnsburger AW, et al.: Interaction of medial temporal lobe atrophy and white matter hyperintensities in AD. Neurology. 2004; 62:1862-1864.
12.
Skoog I: Psychiatric epidemiology of old age: The H70 study. The NAPE lecture, 2003. Acta Psychiatr Scand. 2004; 109: 4-18.
13.
Snowdon DA: Healthy aging and dementia: Findings from the Nun Study. Ann Intern Med. 2003; 139: 450-454.
14.
Doraiswamy PM, Leon J, Cummings JL, et al.: Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2002; 57: M173-M177.
15.
Harris TB: Cholesterol and health in old age: Risk factor or risk marker. J Am Geratr Soc. 2004; 52: 639-640.
16.
Cronin-Stubbs D, Becket LA, Scherr PA, et al.: Weight loss in people with Alzheimer's disease: A prospective population based analysis. BMJ. 1997; 314: 178-179.
17.
Hanlon JT, Artz MB, Pieper CF, et al.: Inappropriate medication use among frail elderly inpatients. Ann Pharmacother. 2004; 38: 914-914.
18.
Laurin D, Masaki KH, Foley DJ, et al.: Midlife dietary intake of antioxidants and risk of late-life incident dementia: The HonoluluAsia Aging Study. Am J Epidemiol. 2004; 159: 959-967.
19.
Forette F, Seux ML, Staessen JA, et al.: Systolic Hypertension in Europe Investigators. The prevention of dementia with antihypertensive treatment: New evidence from the Systolic Hypertension in Europe [Syst-Eur] study. Arch Intern Med. 2002; 162: 2046-2052.
